Stock Chart

BHC

$8.30 -0.66%
Score: 34.8 EXTENDED
LEAPs: SELL $10
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $10
Premium: $1.40
Expiry: Dec 17, 2027
Target: $9
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.31x (vs SPY: 0.6x | vs QQQ: 0.6x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Nov 12, 2026
Symmetrical Triangle weak / forming — below our quality gate quality 46/100
A Symmetrical Triangle is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Historically breaks up 54% overall; 71% up when formed in a downtrend (n=131)
Technical Chart
OVERLAYS
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
SETTINGS
Active (2)
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About BHC - Bausch Health Companies Inc

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Key Statistics

Market Cap $3B

More BHC Analysis

Buy or Sell Analysis Price Prediction AI Analysis Fair Price Options Advisor Trendline Analysis

This BHC stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track BHC's price movements with trendlines, gamma walls, and key support/resistance levels.